Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy

British Journal of Ophthalmology

Volumn 83, Issue 4, 1999, Pages 486-494

  Smith, Gillian ^a   McLeod, David ^a   Foreman, David ^a   Boulton, Mike ^a,b  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; LASER SURGERY; NERVE CELL; PATHOGENESIS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA BLOOD VESSEL; STAINING; TECHNIQUE;

EID: 0032924676     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.4.486     Document Type: Article

References (52)

1. Boulton M, McLeod D, Garner A. Vasoproliferative retinopathies: clinical, morphogenetic and modulatory aspects. Eye 1988;2(Suppl):S124-39.
2. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Research and Treatment 1995;36:127-37.
3. Ferrara N. Vascular endothelial growth factor. The trigger for neovascularization in the eye. Lab Invest 1995;72:615-18.
4. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996;271:603-6.
5. Kolch W, Martiny-Baron G, Kieser A, et al. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Research and Treatment 1995;36:139-55.
6. Ferrara N, Houck KA, Jakeman LB, et al. The vascular endothelial growth factor family of polypeptides. J Cell Bio-chem 1991;46:211-18.
7. Nomura M, Yamagishi S, Harada S, et al. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J-Biol Chem 1995;270:28316-24.
8. Pe'er J, Shweiki D, Itin A, et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995;72:638-45.
9. Pierce EA, Avery RL, Foley ED, et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995;92:905-9.
10. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;92:10457-61.
11. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischaemia-associated iris neovascularization in a non-human primate. Arch Ophthalmol 1996; 114:66-71.
12. Murata T, Ishibashi T, Khalil A, H et al. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 1995;27:48-52.
13. Pe'er J, Folberg R, Itin A, et al. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 1996;80:241-5.
14. Lutty GA, McLeod DS, Merges C, et al. Localization of vascular endothelial growth factor in human retina and choroid.Arch Ophthalmol 1996;114:971-7.
15. Amin RH, Frank RN, Kennedy A, et al Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with non proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:36-47.
16. Boulton M, Foreman D, Williams G, et al. VEGF localisation in diabetic retinopathy. Br J Ophthalmol 1998; 82:561-8.
17. Millauer B, Wizigmann-Voos S, Schnurch H, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993;72:835-46.
18. Breier G, Clauss M, Risau W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Developmental Dynamics 1995;204:228-39.
19. Khaliq A, Foreman D, Ahmed A, et al Increased expression of placenta growth factor (PLGF) in proliferative diabetic retinopathy. Lab Invest 1998;78:109-16.
20. Sawano A, Takahashi T, Yamaguchi S, et al. Fit-1 but not KDR/FLK-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor Cell Growth Differ 1996;7:213-21.
21. Galland F, Karamysheva A, Pebusque M, et al. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 1993;8:1233-40.
22. Borg J, deLapeyriere O, Tetsuro N, et al. Biochemical characterization of two isoforms of FLT4 a VEGF receptor-related tyrosine kinase, Oncogene 1995;10:973-84.
23. Oelrichs RB, Reid HH, Bernard O, et al. NYK/FLK-1: a putative receptor protein tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo. Oncogene 1993;8:11-18.
24. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993;90:8915-19.
25. Quinn TP, Peters KG, De Vries C, et al. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993;90:7533-7.
26. Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994;180: 1141-6.
27. Boocock CA, Charnock-Jones DS, Sharkey AM, et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 1995;87:506-16.
28. Brown LF, Olbricht SM, Berse B, et al. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. Immunol 1995;154:2801-7.
29. Christofori G, Naik P, Hanahan D. Vascular endothelial growth factor and its receptors, flt-1 and flk-15 are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol Endocrinol 1995;9:1760-70.
30. Vaisman N, Gospodarowicz D, Neufield G. Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 1990;265:19461-6.
31. Jakeman LB, Winer J, Bennet GL, et al. Binding sites for vascular endothelial growth factor are localised on endothelial cells in adult rat tissues. J Clin Invest 1992;89:244-53.
32. Terman BI, Khandke L, Dougher-Vermazan M, et al. VEGF receptor subtypes KDR and FLT-1 show different sensitivities to heparin and placenta growth factor. Growth Factors 1994;11:187-95.
33. Thieme H, Aiello LP, Takagi H, et al Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 1995;44:98-103.
34. Brogi E, Schatteman G, Wu T, et al. Hypoxta induced paracrine regulation of vascular endothelial growth factor receptor expression, J Cell Invest 1996;97:469-76.
35. Gitay-Goren H, Cohen T, Tessier S, et al. Selective binding of VEGF121 to one of three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 1996;271:5519-23.
36. Hewett PW, Murray JC. Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells. Biochem Biophys Res Comm 1996;221:697-702.
37. Kendall RL, Wang G, Thomas KA- Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR, Biochem Biophys Res Comm 1996;226:324-8.
38. Adamis AP, Miller JW, Bernai M, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118:445-50.
39. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, N Engl J Med 1994;331: 1480-7.
40. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vas- cular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994;112:1476-82.
41. Waltenberger J, Claesson-Welsh L, Siegbahn A, et al. Different signal transduction properties of KDR and Flt l, two receptors for vascular endothelial growth factor. J Biol Chem 1994;269:26988-95.
42. Joukov V, Pajusola K, Kaipainan A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-8.
43. Simorre-Pinatel V, Guerrin M, Chollet P, et al. Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Ophthalmol Vis Sci 1994;35:3393-400.
44. Takagi H, King GL, Ferrara N, et al. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci 1996;37: 1311-21.
45. Takagi H, King GL, Aiello LP. Identification and characterization of vascular endothelial growth factor receptor (FLT) in bovine retinal pericytes. Diabetes 1996;45:1016-23.
46. Gitay-Goren H, Soker S, Vlodavsky I, et al. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 1992;267:6093-8.
47. Neufield G, Tessler S, Gitay-Goran H, et al. Vascular endothelial growth factor and its receptors. Progress Growth Factor Res 1994;5:89-97.
48. Guerrin M, Moukadiri H, Chollet P, et al. Vasculotropin/ vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vivo. J Cell Physiol 1995;164:385-94.
49. Chen Y, Hackett SF, Schoenfeld C, et al. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol 1997;81:919-26.
50. Murata T, Nakagawa K, Khalil A, et al. The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates. Lab Invest 1996;74:68-77.
51. Stone J, Itin A, Alon T, et al. Development of retinal vascularature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neu-rose 1995;15:4738-47.
52. Strawn LM, McMahon G, App H, et al. Flk-1 as a target for tumour growth inhibition. Cancer Res 1996;56:3540-5.